Join Andelyn’s Newsletter

Your Source for Quality Insights on Cell and Gene Therapies

We are committed to advancing the future of cell and gene therapies. By subscribing to our newsletter, you’ll receive:

Expert perspectives on the latest industry developments

Educational content on therapies from concept to commercialization

Exclusive insights into our pioneering work in rare diseases

Updates on conference attendance and technical presentations

News & Press Releases

News

July 31, 2026

Ohio Life Sciences | National Security Commission on Emerging Biotechnology Visits Ohio as Part of “Biotech Across America” District Spotlight Series Ohio Life Sciences | National Security Commission on Emerging Biotechnology Visits Ohio as Part of “Biotech Across America” District Spotlight Series

News

June 8, 2026

Contract Pharma | Cell & Gene Therapy CDMO Partnerships: Alliances and expertise behind advancing CGTs in today’s market.Contract Pharma | Cell & Gene Therapy CDMO Partnerships: Alliances and expertise behind advancing CGTs in today’s market.

News

May 18, 2026

Manufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certification Manufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certification

Press Release

May 13, 2026

Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program

View All News & Press Releases

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Preferences Deny Accept